LCTX

#3104
Lineage Cell Therapeutics, Inc.
1.5900 USD
+6.00%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.5750
1.5900
Intervallo Annuale
1.4200
1.9850
Variazione giornaliera
+6.00%
Variazione Mensile
+1.27%
Variazione di 6 mesi
-7.40%
Variazione Annuale
-7.40%
Chiusura Precedente
1.5000
Apertura
1.5750
Bid
Ask
Minimo
1.5750
High
1.5900
Volume
240
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 396.0492 M
  • Employee 77
  • Founded 1990
  • CEO N/A
  • Website www.lineagecell.com
  • Headquarter California, United States
  • FIGI BBG000G8RJY6
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.96
Rapporto prezzo/fatturato
26.4

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.

Notizie